Italia markets close in 6 hours 17 minutes

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
14,43+0,29 (+2,05%)
Alla chiusura: 04:00PM EDT
14,48 +0,05 (+0,35%)
Preborsa: 06:04AM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente14,14
Aperto14,19
Denaro14,46 x 3200
Lettera14,48 x 1400
Min-Max giorno14,16 - 14,45
Intervallo di 52 settimane7,09 - 14,45
Volume11.607.816
Media Volume11.008.891
Capitalizzazione16,176B
Beta (5 anni mensile)1,04
Rapporto PE (ttm)N/D
EPS (ttm)-0,50
Prossima data utiliN/D
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendo27 nov 2017
Stima target 1A15,13
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.

  • GlobeNewswire

    Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

    According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA